Metyrosine-associated endocrinological changes in pheochromocytoma and paraganglioma

Metyrosine-associated endocrinological changes in pheochromocytoma and paraganglioma

Objective: Metyrosine (alpha-methyl-para-tyrosine) effectively reduces catecholamine levels in patients with pheochromocytoma/paraganglioma. However, improvements in physiological and metabolic parameters and changes in endocrine function associated with metyrosine administration should be validated...

Full description

Bibliographic Details
Main Authors: Yuko Matsuo, Kenji Ashida, Ayako Nagayama, Kanoko Moritaka, Mizuki Gobaru, Junichi Yasuda, Naoyuki Ogasawara, Hirofumi Kurose, Katsuaki Chikui, Shimpei Iwata, Yukihiro Inoguchi, Nao Hasuzawa, Seiichi Motomura, Tsukasa Igawa, Masatoshi Nomura
Format: Article
Language:English
Published: Bioscientifica 2023-10-01
Series:Endocrine Oncology
Subjects:
pheochromocytoma
paraganglioma
dopamine
diabetes mellitus
prolactin
Online Access:https://eo.bioscientifica.com/view/journals/eo/3/1/EO-23-0006.xml

Internet

https://eo.bioscientifica.com/view/journals/eo/3/1/EO-23-0006.xml

Similar Items